Immunic, Inc.
IMUX
$1.18
-$0.02-1.95%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 23.34% | -4.97% | -25.44% | 13.90% | -16.70% |
| Total Depreciation and Amortization | 20.00% | -4.76% | 38.71% | 65.38% | 52.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16.93% | 85.04% | 25.34% | -78.52% | 36.99% |
| Change in Net Operating Assets | -970.83% | 11.92% | -92.22% | 137.43% | -96.84% |
| Cash from Operations | 16.03% | 3.15% | -44.43% | 9.15% | -63.71% |
| Capital Expenditure | -266.67% | -34.00% | 80.00% | -51.61% | 98.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -266.67% | -34.00% | 80.00% | -51.61% | 98.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -28.92% | -- | -- | -- | -86.26% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -23.38% | -- | -- | -- | -87.25% |
| Foreign Exchange rate Adjustments | 19.07% | -86.70% | 133.67% | 163.79% | -189.70% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16.04% | 2.18% | 332.80% | -142.19% | -79.82% |